Tempol Protects Against Radiation Injury in the Submandibular Gland Through the β‐Catenin Signaling Pathway
Journal of Oral Pathology & Medicine · 2026
DOI: 10.1111/jop.70147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2026. Verfasst von Jinfeng Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China. Hauptthemen laut MEDLINE: beta Catenin, Submandibular Gland, Cyclic N-Oxides, Signal Transduction. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ganzhou Science and Technology Plan Project.
Abstract (Originalsprache)
Background
Radiation damage severely impacts salivary gland function and cell survival, especially in head and neck radiotherapy. Tempol (TPL), a free radical scavenger, has shown protective effects against radiation damage. This research aimed to investigate the protective effects of TPL on radiation‐induced damage in Hs917.T cells and the submandibular gland (SMG) of C57BL/6 mice, along with the mechanisms involved.
Methods
Human parotid fibroblasts (Hs917.T) were pre‐treated with TPL and exposed to ionizing radiation (IR). Protective effects were evaluated using MTT, clonogenic survival assays, flow cytometry, and intracellular reactive oxygen species levels. In vivo, C57BL/6 mice were pre‐treated with TPL (275 mg/kg) and exposed to 15 gray (Gy). Effects were assessed by survival rates, body weight changes, histological analysis, and TUNEL staining. Changes in apoptosis‐related markers and β‐catenin signaling pathway were analyzed, and the role of TPL was verified using the β‐catenin inhibitor XAV939.
Results
TPL pre‐treatment increased cell survival, reduced apoptosis, alleviated cell cycle arrest, and decreased intracellular superoxide and hydrogen peroxide levels in Hs917. T cells. In C57BL/6 mice, pre‐treatment with TPL improved survival, mitigated weight loss, reduced SMG damage, and decreased apoptosis. TPL inhibited IR‐induced apoptosis by increasing Bcl‐2 expression and decreasing Bax and caspase‐9 levels. TPL exerted anti‐apoptotic and protective effects by upregulating the expression of β‐catenin, promoting its nuclear translocation, and inhibiting its phosphorylation. These protective effects of TPL were reversed by XAV939.
Conclusions
TPL exerted protective effects against IR‐induced damage in Hs917.T cells and the SMG of C57BL/6 mice through activating the β‐catenin signaling pathway, inhibiting cell apoptosis, and alleviating oxidative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
- Jiangxi "Flagship" Oncology Department of Synergy for Chinese and Western Medicine, Ganzhou, China.
- Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development, Ganzhou, China.
- The First Clinical Medical College, Gannan Medical University, Ganzhou, China.
- Department of Intensive Care Medicine, Ganzhou People's Hospital, Ganzhou, China.
ORCID-Profile: Jinfeng Wang, Chao Liu
Förderung
- Ganzhou Science and Technology Plan Project
Zitieren
APA
Wang, J., Xu, M., Zhong, J., Zhong, K., Chen, Z., Liu, C., & Liu, C. (2026). Tempol Protects Against Radiation Injury in the Submandibular Gland Through the β‐Catenin Signaling Pathway. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.70147
Vancouver
Wang J, Xu M, Zhong J, Zhong K, Chen Z, Liu C, et al. Tempol Protects Against Radiation Injury in the Submandibular Gland Through the β‐Catenin Signaling Pathway. Journal of Oral Pathology & Medicine. 2026. doi:10.1111/jop.70147
BibTeX
@article{Wang2026,
author = {Wang, Jinfeng and Xu, Mingjun and Zhong, Jinghua and Zhong, Kui and Chen, Zheng and Liu, Chunyu and Liu, Chao},
title = {Tempol Protects Against Radiation Injury in the Submandibular Gland Through the β‐Catenin Signaling Pathway},
journal = {Journal of Oral Pathology & Medicine},
year = {2026},
doi = {10.1111/jop.70147}
}
EUVIMED